Aleafia Health Inc. (ALEAF)

[happyglass]

I have a family member who is a patient with Aleafia (Emblem) they have had no issues getting medication in quite a while, they used to have to place orders with other companies because somebody was always out of products, but has not had to do that for a long time. I know you can not judge by one person’s experience but it does give a good sign :) They actually do not order from any of the others because Emblem has the best prices and 2.0 formats. They were the first with vapes and the kinslips are very effective. I have a neighbour (elderly and “anti pot”) who is dealing with a recurrence of cancer. The kinslips have reduced their pain like magic. Nothing beats first hand experience.
Lets hope for goid news on the 11th

[$oldier Hard]

1 working day to go.

[$oldier Hard]

If a repeat of supply issues nothing we can do about it except buy more.

Headed to soccer practice.

[$oldier Hard]

Yeah buddy, she'll turn imo.

[FUNMAN]

IMO, every Q this year is important confirmation of them doing the right things or not.

The 2021 Q1 report should be solid as expected.

But what if there is a repeat of supply issues that hammered revs at the end of last year. No one expected them to basically run out of supply.

Did they fix it? Will they be able to satisfy demand in Q3 when the big outdoor harvest isn't yet in.

Therefore, to no ones surprise, I'm thinking they need to continuously post rising QoQ revenues just as the big USA MSO's are doing.

It's time to get beyond talking-the-talk. They have to walk-the-walk.

So the question isn't "is this the quarter that changes things?"

The real question is, "is this the year that changes things?"

$ALEAF is this the quarter that changes things? 4 working days to go. - '$oldier Hard'

[Diogenes of Sinope]

ALEAF

We all hope to see some green in the near future.

[$oldier Hard]

$ALEAF is this the quarter that changes things? 4 working days to go.

[FUNMAN]

Aleafia Health Inc. will announce its 2021 first quarter results on May 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EDT. The call will be hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand.

[$oldier Hard]

Thx FUN. Was gone all day and see not much reaction to great $ALEAF news.

[Tabbysan]

Cool! ALEAF!

[FUNMAN]

Aleafia Health Secures Health Canada Research Licence for Human Sensory Analysis Trials of Cannabis Products

TORONTO, May 3, 2021 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”), a global leader in cannabis wellness products and services, has secured a Health Canada Research Licence for its cannabis product manufacturing and innovation centre in Paris, Ont. The licence allows the Company to conduct human sensory analysis and palatability trials, evaluating the taste, touch, smell and sight of its growing portfolio of differentiated medical and consumer cannabis products.

“As we continue to bring highly innovative formats to market, our development team will now employ an important best practice of product evaluation used in the food and beverage industries,” said Aleafia Health CEO Geoffrey Benic. “Through a first to market product strategy, we’ve developed a track record for product innovation that will only be strengthened by this regulatory breakthrough.”

Aleafia Health is currently developing a number of new product formats and line extensions to complement its existing cannabis portfolio of dried flower, edibles, sublingual strips, soft gels, extracts, and vape cartridges. The Company intends to conduct sensory assessment studies consistently during product development, allowing human panels to evaluate objective product characteristics, and evaluate preference between comparable products.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
[e-mail]
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

[happyglass]

It takes a long time to be an over night success :)

[macman95835]

Been hearing this since 2017 lol

[macman95835]

Can’t wait u til it’s closer to $1. Take all loses and get the f$&@ out of this turd. Been waiting since 2017 and it gets worst every month.

[Tabbysan]

This stock could be $5 to $10 a year from now. ALEAF!

[Tabbysan]

Why? I have a drip schedule buy Monday a.m. ALEAF!

[macman95835]

Are we done with this one?

[$oldier Hard]

At a glance very nice for $ALEAF. I gotta run out for a couple/few hrs and will read completely when I get back.

Ty FUN.

[FUNMAN]

Very nice--->>>Aleafia CORPORATE PRESENTATION APRIL 2021


https://www.aleafiahealth.com/uploads/2020/09/2021.04.15-Corporate-Presentation.pdf

[happyglass]

Here is a cute video of a girl with a migraine trying Aleafia’s Emblem Park Life KinSlips for the first time

[happyglass]

That has not been my experience in the weed space but it truly matters not to me. I see what this company is doing and they make products that make people feel better. I am casting a net that is global. There has never been a better time to invest on cannabis.

[macman95835]

They never do it after hours they always deliver the shitty news in the morning

[Tenseevol]

https://www.aleafiahealth.com/news-releases/aleafia-health-ceo-geoffrey-benic-to-present-in-two-investor-conferences/

[FUNMAN]

Aleafia Health to Webcast Live at VirtualInvestorConferences.com April 20th

Mon, April 19, 2021, 8:35 AM·2 min read


Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

TORONTO, April 19, 2021 /PRNewswire/ -- Aleafia Health Inc. (TSX: AH) (OTC: ALEAF), a leader in cannabis wellness products and brands, today announced that Geoffrey Benic, chief executive officer, will present live at VirtualInvestorConferences.com on April 20th.

DATE: Tuesday, April 20th

TIME: 11:00 ET

LINK: https://bit.ly/31A39N3

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Fourth Quarter 2020 Highlights

233% increase in Q/Q cannabis net revenue

$4.3 million positive adjusted EBITDA in Q4 2020

42% and 501% increase in Q/Q medical cannabis and adult-use net revenue, respectively

Significant product portfolio expansion with 31 new SKUs launched since October

About Aleafia Health:
Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access. Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

multimedia:http://www.prnewswire.com/news-releases/aleafia-health-to-webcast-live-at-virtualinvestorconferencescom-april-20th-301271202.html

SOURCE VirtualInvestorConferences.com

[happyglass]

They are announcing before open that is a good sign. If it was bad they would announce after market on a Friday. It will still dump weed stocks always play the buy the rumour sell the news but I think they will do very well. Their new products are excellent.

[FUNMAN]

Thoughts--->>>Aleafia Health to Announce 2021 First Quarter Results

Thanks for the heads-up 'Diogenes of Sinope'.

To bad mgmt hasn't said anything about the coming Q ER.

They've been mum. Is it possible they are not proud? Because we know that when they are proud, they put out PRs.

Are we waiting to see another "ER bleeder"?

Let's hope that what they indicated months ago comes true. That a lot of new shipments commenced during the 2021 Q1. - FUNMAN

TORONTO – April 16, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2021 first quarter results on May 11, 2021 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Geoffrey Benic and CFO Benjamin Ferdinand.

CONFERENCE CALL & WEBCAST

Date: May 11, 2021
Time: 8:30 a.m. EST
USA/Canada Toll-Free Participant Call-in: [phone]; Passcode: 3486978
International Toll-Free Participant Call-in: [phone]; Passcode: 3486978

WEBCAST LINK

This conference call will be webcast live over the internet and can be accessed through the link provided. Audio of the call will be available to participants through both the conference call line and webcast; however, the presentation may only be viewed via the webcast. Participants who miss the live call can view a replay at any time via the link provided.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
[e-mail]
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

[Diogenes of Sinope]

Aleafia Health to Announce 2021 First Quarter Results

https://www.globenewswire.com/news-release/2021/04/16/2211581/0/en/Aleafia-Health-to-Announce-2021-First-Quarter-Results.html

[macman95835]

This is what every q everyone is hoping. On a good PR only this stock goes down.

[Tabbysan]

Greater than 5k shares holding here now :)

[happyglass]

I do not know how the timing of all their new products will show on the next fins but their Bogart’s Kitchen gummies are now available so if not this report the next ones will....

[FUNMAN]

2 new Aleafia SKUs using low all-in-cost outdoor grow. That's the reference they are making when they say "competitive advantage". --->>>

Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels

Thanks for the find 'Diogenes of Sinope'

Read the release here to see the new product pictures.

https://aleafiahealth.com/news-releases/aleafia-health-introduces-wellness-brand-noon-night-featuring-omega-cbd-soft-gels/

TORONTO, April 13, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its trailblazing new cannabis wellness brand Noon & Night. It launches with two new innovative product formats, the first of its kind Omega CBD Soft Gels and Lavender Fizz CBD bath bombs, both of which are now available in the adult-use market.

“Noon & Night is highly differentiated, filling a clear gap in the cannabis brand landscape with its exclusive focus on health and wellness conscious consumers,” said Aleafia Health CEO Geoffrey Benic. “This forms an important part of our concerted entrance into the Canadian adult-use market, perfectly complementing our recently launched edibles brand Bogart’s Kitchen and everyday cannabis brand Divvy. The consistent theme in the rapid expansion of our product portfolio is through leaning on our core competitive advantages.”

The Omega CBD Soft Gels feahttps://www.thesundaymarket.com/ture full-spectrum, single strain CBD extract, and are the first Canadian cannabis products to be suspended in fish oil containing omega-3. Omega-3s are an essential fatty acid, and one of the most popular nutritional supplements in North America.[1] [2] Additionally, many patients and consumers prefer soft gels as they are easier to swallow, relative to dissolvable capsules. Each soft gel contains 30 mg of CBD, with 30 soft gels per bottle.

The Lavender Fizz CBD bath bombs are handcrafted and locally produced at the Company’s Paris, Ont. product innovation centre. Made with locally sourced lavender flower, they contain no artificial dyes or colours, and each contain 100 mg of CBD. They also boast the most accessible price point in their product category in the adult-use market.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
[e-mail]
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Government of Canada, S. (2017, June 20). Health Fact Sheet: use of nutritional supplements, 2015. https://www150.statcan.gc.ca/n1/pub/82-625-x/2017001/article/14831-eng.htm

[ii] The Council for Responsible Nutrition. “Dietary Supplement Use Reaches All Time High.” (2019, September 30). https://www.crnusa.org/newsroom/dietary-supplement-use-reaches-all-time-high

[Diogenes of Sinope]

Aleafia Health Introduces Wellness Brand Noon & Night Featuring Omega CBD Soft Gels

https://www.google.ca/amp/s/finance.yahoo.com/amphtml/news/aleafia-health-introduces-wellness-brand-113000322.html

[fignewton]

Aphria struggled in their latest Q. Will Aleafia have the same story? Aphria complained about the lockdown in Ontario, but Aleafia has their delivery service so it could be possible Aleafia took market share away from Aphria! Did Aleafia launch recreational products that will be included in revenue for the next reportable Q?

[radly]

God man, great post, you're a genius

[Taurus69]

$aleaf $0.51 ^ 0.0241 (4.96%)
Volume: 183,668 @04/09/21 3:58:06 PM EDT

[FUNMAN]

1 Small Canadian Cannabis Stock Analysts Seem to Like Right Now

Chris MacDonald
April 11, 2021

Recently, cannabis stocks have seen massive growth amid burgeoning investor demand. Legalization efforts in the U.S. seem likely to play out in the near-term. Accordingly, there remains a tonne of investors interest in this space.

This investor interest has not escaped Canadian cannabis companies. Smaller-cap Canadian cannabis players have seen some pretty wild moves of late. Indeed, stocks like Aleafia Health Inc.(TSX:AH) have been big movers of late.

On a year-to-date basis, Aleafia stock is up 30%. That’s not bad. However, the stock is also down more than 50% from its February peak. This is a highly volatile play, and is made more volatile by its smaller market cap.

That said, analysts have recently been more bullish on this stock. Here’s why.

Bullish analyst sentiment on Aleafia

Recently, Raymond James analyst Rahul Sarugaser provided an “outperform” recommendation for Aleafia. This vote of confidence was given for multiple reasons.

First, Aleafia’s business model is one that is viewed as beneficial for long-term growth. Specifically, the company’s relatively low-cost production, top-rated cultivation and manufacturing facilities, and an array of innovative pot-based products are among the key drivers. These are key facets of any long-term investment, so this appears to be very bullish for fundamentals-oriented investors.

Additionally, Aleafia recently secured an exclusive deal with large private-sector union Unifor. This deal will support medical pot coverage for nearly 315,000 family members. Thus, expectations are that this deal could provide significant revenue growth in the second half of 2021.

Furthermore, Aleafia has been broadening its product offering. The company is set to launch a host of new SKUs aimed at the recreational cannabis market. This would supplement the company’s already diverse product portfolio.

Accordingly, the expectation is that continued growth in sales of the company’s new products, combined with its high-margin derivative products, could provide for continued strong revenue growth. The company’s net revenue growth rate of 233$ in Q4 2020 speaks to the amount of growth this company has already provided. Any sort of acceleration on this front could be very bullish for this stock.

Conclusion

The cannabis sector continues to be a highly-volatile growth market today. Accordingly, investors with lower risk tolerance levels need to consider this fact before jumping in.

Indeed, Aleafia’s stock price swings this year are an indication of how much sentiment can shift these stocks’ values in short order. While it appears the company has one analyst in its corner, the market will ultimately decide the fate of this company.

Being on the right side of the trade for such speculative plays isn’t easy. Therefore, I’m on the sidelines with respect to Aleafia right now.

[$oldier Hard]

14 stores open with 7 more to open soon.

[FUNMAN]

One Plant up to 14 open stores. I hope Aleafia is selling through a lot of their product to them.

https://www.oneplant.ca/stores/

Aleafia's 10% stake is hopefully paying off in more ways than one.

[$oldier Hard]

That's good news FUN. Would be nice to see the market respond positively.

[FUNMAN]

Aleafia Health Launches Everyday Cannabis Brand Divvy

I presume if they are touting their price advantages, Divvy comes from the outdoor cultivation. That should allow for a very low price point. Maybe even competitive with the black market.

They don't give that detail. - FUNMAN

https://aleafiahealth.com/news-releases/aleafia-health-launches-everyday-cannabis-brand-divvy/

TORONTO, April 7, 2021 – Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce the launch of its everyday cannabis brand Divvy, tailored to frequent cannabis consumers who are both price and quality conscious.

“Led by our experienced growers, Aleafia Health has developed a long track record of cultivating high quality cannabis. But it’s only now through our expanded production footprint that we are producing quality dried flower at scale,” said Aleafia Health CEO Geoffrey Benic. “We continue our entrance into the adult-use market in a meaningful way with our Sunday Market brand family, targeting our key competitive advantages. With Divvy, the proposition for frequent cannabis consumers is based on quality, price point, and a product that is environmentally sustainable, both in its cultivation and packaging.”


Divvy launches in adult-use markets with five new dried flower and pre-roll SKUs, including three different 12 x 0.35g pre-roll multipacks which feature premium, reusable tin packaging. Throughout 2021, the Company expects to add to the Divvy portfolio with larger quantity line extensions, new cultivars, and new, non-flower formats. The new brand portfolio benefits from Aleafia Health’s low-cost cannabis cultivation advantage.

Together, pre-rolls and dried flower represented 70 per cent of total legal cannabis sales during the three months ended December 31, 2020, according to data from the Ontario Cannabis Store. Shipments of Divvy products have been completed to provincial adult-use wholesalers. Divvy is the second new brand launched under the Sunday Market brand family, each targeting a specific consumer segment and featuring its own roster of cannabis products.

For Investor & Media Relations:

Nicholas Bergamini, VP Investor Relations
1-833-879-2533
[e-mail]

LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and with sales and operations in Australia and Germany. The Company operates medical clinics, education centres and production facilities for the production and sale of cannabis.

Aleafia Health owns four significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules, edibles, sublingual strips, and vapes. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and operates internationally in three continents.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

[macman95835]

Yeah, really disappointed.

[Tabbysan]

What's going on over here? I keep adding but price keeps falling? ALEAF!

[happyglass]

Probably not. It is Canadian and it does not have any operations in the USA. It is however very well positioned in the Canadian market and beyond which allows it freedom globally the US companies can not access. You have to know what you own

[Chrism0000]

So now that they're making it legal in New York City will this company ever get off its feet and move

[happyglass]

This new revelation that Biden is anti legalization will help Aleafia. They are not burdened by the grow house baggage the early LPs have yet they have international exposure the US can not. 2nd mover advantage is Aleafia’s best asset

https://www.marijuanamoment.net/bidens-opposition-to-marijuana-legalization-has-not-changed-press-secretary-says/

[happyglass]

So cannabis is not the problem for mental illness in youth, the thing it replaces (alcohol) is!!
https://hightimes.com/health/science/study-shows-alcohol-impacts-cortical-thickness-young-adults-cannabis-does-not/?amp

Study Shows Alcohol Impacts Cortical Thickness in Young Adults, Cannabis Does Not By
Addison Herron-Wheeler
19 hours ago

A new study refutes what many claim is a danger of legal cannabis, as the findings showed that, while alcohol can have an impact on cortical thickness in younger users, cannabis does not. 
The study, titled “The effects of alcohol and cannabis use on the cortical thickness of cognitive control and salience brain networks in emerging adulthood: A co-twin control study,” was published in the journal Biological Psychiatry and conducted by researchers at the University of Minnesota.
These researchers looked at the relationship between alcohol and cannabis exposure when it comes to the brain morphology of young adults. It considered a population-based sample of 436 twins, all 24 years old. By looking at frequency, density, quantity, and level of intoxication from both alcohol and cannabis, the researchers were able to gather data about how cannabis impacts cortical thickness. The cortical consistency was measured using magnetic resonance imaging. 
When conducting this research, the team kept in mind that other studies often assume that even casual substance exposure can have an impact on brain structure. However, until now, this was a largely untested theory, and one that does not take other factors like familiar risk into account. By studying the twins who were using alcohol and cannabis, the study was able to directly measure how the two different substances can affect people.
The study explained,  “Greater alcohol, but not cannabis, misuse was associated with reduced thickness of prefrontal and frontal medial cortices, as well as [the] temporal lobe, intraparietal sulcus, insula, parietal operculum, precuneus, and parietal medial areas.”
Related Post
1. ?

2. ??New Mexico Lawmakers To Have Special Legislative Session On Marijuana Law ReformA previous effort to legalize cannabis fell short, but Governor Grisham isn't done fighting.?
Why These Findings Matter
The reason this research is so important is that intellectual ability is thought to be related to brain structure, including how thick the cerebral cortex is. Thus, it is very important to understand how substances and other impacts can change that thickness. But, in the case of cannabis, it seems the thickness wasn’t changed much.
“No significant associations between cannabis use and thickness were observed,” the study concluded. This study provides novel evidence that alcohol-related reductions in cortical thickness of control/salience brain networks likely represent the effects of alcohol exposure and premorbid characteristics of the genetic predisposition to misuse alcohol. The dual effects of these two alcohol-related causal influences have important and complementary implications regarding public health and prevention efforts to curb youth drinking.”
This is consistent with the findings of other studies, literature reviews, and papers, most of which claim that any damage done is probably from alcohol, not from cannabis. A literature review of many studies posted in JAMA Psychiatry explains that, “Associations between cannabis use and cognitive functioning in cross-sectional studies of adolescents and young adults are small and may be of questionable clinical importance for most individuals. Furthermore, abstinence of longer than 72 hours diminishes cognitive deficits associated with cannabis use. Results indicate that previous studies of cannabis youth may have overstated the magnitude and persistence of cognitive deficits associated with marijuana use.”
As the world opens up for more research about cannabis to be done, no doubt more misconceptions will be dispelled.

[happyglass]

No they are not. They are making progress at a good rate compared to their competition. Canopy had a first mover advantage that they seem to be working at losing. This write down of the non existent goodwill was a hangover from the giddy days of silly evaluations. They got off easy compared to aurora and canopy and other big names who have shuttered big expensive greenhouses and written down billions. With that goodwill (referred to by some accountants as goodwill and other nothings) they have the way clear for growth going forward. I think your patience will be rewarded in the next year and on into the future. The CEO spoke correctly when he referred to their second mover advantage. The Canadian rollout has been a nightmare but it is finally starting to get a balance. There are Symbl products on the shelves in stores and Emblem is on line and anyone ordering medicine in the GTA gets same day delivery. The party is about to start.

[macman95835]

Don’t get me wrong. Been invested for the last 4 years but @&$k we are in deep s@@t again. How!? Why!?

[happyglass]

What are you upset about? Cleaning up the balance sheet? Striking a deal to be the supplier to Canada’s biggest union? Onboarding more patients? Launching new SKUs to a captive audience? I know Canada is dismissed by the US but it IS the size of California and has very few competitors by comparison.

[macman95835]

Not sure what will happen from now on. Losing hopes and very upset with management.